Although lung cancer screening ... A Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions Mar. 17, 2025 — In the continuing evolution of personalized medicine, a new study has ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

For patients with EGFR-mutated NSCLC, treatment options in the frontline include osimertinib monotherapy, amivantamab with ...

After decades of hype and setbacks, scientists have made impressive progress into tricking stem cells into repairing organs.

Late-breaking findings on pulmonology, critical care, and sleep medicine will be presented at the American Thoracic Society ...

Higher-than-usual doses of radiation in the treatment of inoperable lung cancer can be safely combined with immunotherapy ...

Banner University Medical Center in Tucson is making history as the first hospital in Arizona to offer a groundbreaking ...

Dr. Suresh S. Ramalingam explains that patients with stage 3 lung cancer who undergo chemotherapy and radiation may develop ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Radiotherapy is a highly effective treatment for lung cancer, yet the heart is often located close to the tumor site. It is ...

Radiotherapy is a highly effective treatment for lung cancer, yet the heart is often located close to the tumor site. It is important that the dose to the heart is minimized to reduce the risk of ...

Radiotherapy is a highly effective treatment for lung cancer, yet the heart is often located close to the tumor site. It is ...